Molecular Testing for Thyroid Follicular Lesions of Uncertain Significance (FLUS)? (AMW)
2021 AAO-HNSF Annual Meeting & OTO Experience
This presentation will present a very practical when and how to apply molecular marker testing in select thyroid nodules, AUS/FLUS (Bethesda 3) and Follicular Neoplasm (Bethesda 4). Available testing on the market will be reviewed without any commercial bias.
Credits
CME:1.0, MOC:1.0
![Molecular Testing for Thyroid Follicular Lesions of Uncertain Significance (FLUS)? (AMW) AMW21 Logo](https://cdn.mycrowdwisdom.com/aao-hnsf/productImage/OTO-LogicIcons_AmW21-1712158988302.png)